Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia

Journal of Human Genetics

Volumn 58, Issue 2, 2013, Pages 91-97

  Nishioka, Masaki ^a   Bundo, Miki ^a   Koike, Shinsuke ^a   Takizawa, Ryu ^a,b   Kakiuchi, Chihiro ^a   Araki, Tsuyoshi ^a   Kasai, Kiyoto ^a   Iwamoto, Kazuya ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

biomarker; CpG island; epigenetics; first episode psychosis; gender difference

Indexed keywords

NUCLEOTIDE; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; COMTD1 GENE; CONTROLLED STUDY; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENE; HTR1E GENE; HUMAN; MALE; MENTAL PATIENT; PROMOTER REGION; PROTEIN BINDING; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE; PRINCIPAL COMPONENT ANALYSIS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84875422528     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2012.140     Document Type: Article

References (41)

1. Gershon, E. S., Alliey-Rodriguez, N. & Liu, C. After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. Am. J. Psychiatry. 168, 253-256 (2011).
2. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D. et al. Common variants conferring risk of schizophrenia. Nature. 460, 744-747 (2009).
3. O'Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V. et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40, 1053-1055 (2008).
4. Ripke, S., Sanders, A. R., Kendler, K. S., Levinson, D. F., Sklar, P., Holmans, P. A. et al. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976 (2011).
5. Sharma, R. P., Grayson, D. R. & Gavin, D. P. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr. Res. 98, 111-117 (2008).
6. Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A. et al. Reelin promoter hypermethylation in schizophrenia. Proc. Natl Acad. Sci. USA. 102, 9341-9346 (2005).
7. Abdolmaleky, H. M., Cheng, K. H., Russo, A., Smith, C. L., Faraone, S. V., Wilcox, M. et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B, 60-66 (2005).
8. Abdolmaleky, H. M., Cheng, K. H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F. et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15, 3132-3145 (2006).
9. Iwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama-Shigeno, Y., Yoshikawa, T. et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 25, 5376-5381 (2005).
10. Tolosa, A., Sanjuan, J., Dagnall, A. M., Molto, M. D., Herrero, N. & de Frutos, R. FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies. BMC Med. Genet. 11, 114 (2010).
11. Pun, F. W., Zhao, C., Lo, W. S., Ng, S. K., Tsang, S. Y., Nimgaonkar, V. et al. Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor beta(2) subunit. Mol. Psychiatry. 16, 557-568 (2011).
12. Abdolmaleky, H. M., Yaqubi, S., Papageorgis, P., Lambert, A. W., Ozturk, S., Sivaraman, V. et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr. Res. 129, 183-190 (2011).
13. Dempster, E. L., Mill, J., Craig, I. W. & Collier, D. A. The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC Med. Genet. 7, 10 (2006).
14. Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L. et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 82, 696-711 (2008).
15. Tochigi, M., Iwamoto, K., Bundo, M., Komori, A., Sasaki, T., Kato, N. et al. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol. Psychiatry. 63, 530-533 (2008).
16. Carrard, A., Salzmann, A., Malafosse, A. & Karege, F. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J. Affect. Disord. 132, 450-453 (2011).
17. Ghadirivasfi, M., Nohesara, S., Ahmadkhaniha, H. R., Eskandari, M. R., Mostafavi, S., Thiagalingam, S. et al. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156, 536-545 (2011).
18. Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M. R., Ahmadkhaniha, H., Thiagalingam, S. et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J. Psychiatr. Res. 45, 1432-1438 (2011).
19. Melas, P. A., Rogdaki, M., Osby, U., Schalling, M., Lavebratt, C. & Ekstrom, T. J. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FA S E B J. 26, 2712-2718 (2012).
20. Dempster, E. L., Pidsley, R., Schalkwyk, L. C., Owens, S., Georgiades, A., Kane, F. et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum. Mol. Genet. 20, 4786-4796 (2011).
21. Murphy, B. C., O'Reilly, R. L. & Singh, S. M. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 133B, 37-42 (2005).
22. Sugawara, H., Iwamoto, K., Bundo, M., Ueda, J., Miyauchi, T., Komori, A. et al. Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. Transl. Psychiatry. 1, e24 (2011).
23. Kaminsky, Z., Tochigi, M., Jia, P., Pal, M., Mill, J., Kwan, A. et al. A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol. Psychiatry. 17, 728-740 (2012).
24. McGlashan, T. H., Miller, T. J. & Woods, S. W. Structured Interview for Prodromal Syndromes (version 3.0). (PRIME Research Clinic, Yale School of Medicine, New Haven, 2001).
25. Bibikova, M., Le, J., Barnes, B., Saedinia-Melnyk, S., Zhou, L., Shen, R. et al. Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics. 1, 177-200 (2009).
26. Lucas, A. & Jasson, S. Using amap and ctc packages for huge clustering. R News. 6, 58-60 (2006).
27. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA. 98, 5116-5121 (2001).
28. Efron, B. & Tibshirani, R. Empirical bayes methods and false discovery rates for microarrays. Genet. Epidemiol. 23, 70-86 (2002).
29. Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
30. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
31. Szymanski, S., Lieberman, J. A., Alvir, J. M., Mayerhoff, D., Loebel, A., Geisler, S. et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am. J. Psychiatry. 152, 698-703 (1995).
32. Shimabukuro, M., Sasaki, T., Imamura, A., Tsujita, T., Fuke, C., Umekage, T. et al. Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia. J. Psychiatr. Res. 41, 1042-1046 (2007).
33. Bromberg, A., Levine, J., Nemetz, B., Belmaker, R. H. & Agam, G. No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients. Schizophr. Res. 101, 50-57 (2008).
34. Xu, B., Roos, J. L., Dexheimer, P., Boone, B., Plummer, B., Levy, S. et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat. Genet. 43, 864-868 (2011).
35. Kinoshita, M., Numata, S., Tajima, A., Shimodera, S., Ono, S., Imamura, A. et al. DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromol. Med. (e-pub ahead of print 9 September 2012; doi:10.1007/s12017-12012- 18198-12016).
36. Vandenbergh, D. J., Thompson, M. D., Cook, E. H., Bendahhou, E., Nguyen, T., Krasowski, M. D. et al. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyper-activity disorder populations. Mol. Psychiatry. 5, 283-292 (2000).
37. Lin, C. H., Hansen, S., Wang, Z., Storm, D. R., Tapscott, S. J. & Olson, J. M. The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning. Proc. Natl Acad. Sci. USA. 102, 14877-14882 (2005).
38. Pinto, L., Drechsel, D., Schmid, M. T., Ninkovic, J., Irmler, M., Brill, M. S. et al. AP2gamma regulates basal progenitor fate in a region-and layer-specific manner in the developing cortex. Nat. Neurosci. 12, 1229-1237 (2009).
39. Banister, C. E., Koestler, D. C., Maccani, M. A., Padbury, J. F., Houseman, E. A. & Marsit, C. J. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics. 6, 920-927 (2011).
40. Bell, C. G., Teschendorff, A. E., Rakyan, V. K., Maxwell, A. P., Beck, S. & Savage, D. A. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med. Genomics. 3, 33 (2010).
41. Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P. & Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry. 62, 975-983 (2005).